Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 6 (June)

1. Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?
   Curr Opin Rheumatol, 20(4): 450-6. [Abstract] [Full-text]
2. Gene array analysis comparison between rat collagen-induced arthritis and human rheumatoid arthritis.
   Scand J Immunol, 68(1): 43-57. [Abstract] [Full-text]
3. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
   Scand J Immunol, 68(1): 103-11. [Abstract] [Full-text]
4. How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
   BMC Complement Altern Med, 8: 25. [Abstract] [Full-text]
5. Medicaid prescription formulary restrictions and arthritis treatment costs.
   Am J Public Health, 98(7): 1300-5. [Abstract] [Full-text]
6. Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders.
   J Orthop Res, 26(7): 910-7. [Abstract] [Full-text]
7. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.
   Rheumatology (Oxford), 47(7): 1088-92. [Abstract] [Full-text]
8. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis.
   Rheumatology (Oxford), 47(7): 1082-7. [Abstract] [Full-text]
9. Assessment of anti-TNF-alpha efficacy in rheumatoid arthritis: is 3 months sufficient?
   Rheumatology (Oxford), 47(7): 1073-6. [Abstract] [Full-text]
10. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population.
    Rheumatology (Oxford), 47(7): 1061-4. [Abstract] [Full-text]
11. Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept.
    Rheumatology (Oxford), 47(7): 1044-50. [Abstract] [Full-text]
12. Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.
    Rheumatology (Oxford), 47(7): 1000-5. [Abstract] [Full-text]
13. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis.
    Rheumatology (Oxford), 47(7): 985-90. [Abstract] [Full-text]
14. Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study.
    Rheumatology (Oxford), 47(7): 991-5. [Abstract] [Full-text]
15. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis.
    Rheumatology (Oxford), 47(7): 980-4. [Abstract] [Full-text]
16. Synovial VLA-1+ T cells display an oligoclonal and partly distinct repertoire in rheumatoid and psoriatic arthritis.
    Clin Immunol, 128(1): 75-84. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.